Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Keio, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 25%
9008 Keio Corporation 【J-GAAP】
Earnings ReportKeio Corporation <9008> [TSE Prime] announced its financial results after the market closed on February 10th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) increased 24.7% from the same period last year, reaching 49.1 billion yen. The progress rate toward the full-year plan of 53.6 billion yen was 91.7%, it was below the five-year average of 106.3%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to grow 9.7% from the same period last year, reaching 4.47 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 13.2% from the same period last year, reaching 17.9 billion yen. The operating profit margin rose from 14.2% in the same period last year to 14.8%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 251,888 | 18,838 | 19,088 | 12,723 | 104.2 | 87.7 | Feb 6, 2023 | J-GAAP |
Apr - Dec, 2023 | 294,056 | 39,500 | 39,409 | 25,362 | 207.7 | 90.6 | Feb 5, 2024 | J-GAAP |
Apr - Dec, 2024 | 334,874 | 49,578 | 49,127 | 39,177 | 321.4 | 91.7 | Feb 10, 2025 | J-GAAP |
YoY | +13.9% | +25.5% | +24.7% | +54.5% | +54.7% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 224,636 | 19,932 | 19,904 | 12,029 | 98.5 | 30 | May 10, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 255,811 | 23,266 | 22,395 | 15,876 | 134.2 | 50 | Nov 6, 2024 | J-GAAP |
YoY | +13.9% | +16.7% | +12.5% | +32.0% | +36.3% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 347,133 | 21,479 | 21,772 | 13,114 | 107.4 | 40 | May 12, 2023 | J-GAAP |
Mar, 2024 | 408,694 | 43,840 | 43,485 | 29,243 | 239.5 | 52.50 | May 10, 2024 | J-GAAP |
Mar, 2025 Guidance | 470,000 | 55,000 | 53,600 | 41,000 | 346.7 | 100 | Nov 6, 2024 | J-GAAP |
YoY | +15.0% | +25.5% | +23.3% | +40.2% | +44.8% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 109,998 | 15,592 | 15,828 | 8,148 | 66.7 | 14.2 | Feb 5, 2024 | J-GAAP |
Jan - Mar, 2024 | 114,638 | 4,340 | 4,076 | 3,881 | 31.8 | 3.8 | May 10, 2024 | J-GAAP |
Apr - Jun, 2024 | 104,720 | 16,892 | 17,025 | 14,548 | 119.1 | 16.1 | Aug 6, 2024 | J-GAAP |
Jul - Sep, 2024 | 109,469 | 14,842 | 14,180 | 10,576 | 86.6 | 13.6 | Nov 6, 2024 | J-GAAP |
Oct - Dec, 2024 | 120,685 | 17,844 | 17,922 | 14,053 | 115.3 | 14.8 | Feb 10, 2025 | J-GAAP |
YoY | +9.7% | +14.4% | +13.2% | +72.5% | +72.8% |
Related Articles
NIPPON CHEMI-CON, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 81%, Oct-Dec Ordinary Profit Decreases by 16%
AIGAN, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Turns to Loss
SAITA, Oct-Dec (2Q) Ordinary Profit Increases by 2.7 times
YUKEN KOGYO, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 28%, Oct-Dec Ordinary Profit Increases by 17%
COMO, Oct-Dec (3Q) Ordinary Profit Decreases by 92%
MATSUYA FOODS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 4%, Exceeds Full-Year Plan
D.Western Therapeutics Institute, The Current Fiscal Year's Net Income to Narrow
ASAHI RUBBER, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 48%
EBARA JITSUGYO, 5% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Raised by 25 yen
Medical Data Vision, Returning to Profitability This Year, Dividend Raised by 2.5 yen